ABCG2 and epilepsy: While aging and AD showed chronic loss of certain transporters, in epilepsy a compensatory overexpression of ABCB1 and ABCG2 transporting xenobiotics and drugs out of the CNS is a common feature and appears associated with pharmacoresistance [134,135].